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We test the backward haplotype transmission association algo-
rithm on genome-scan data previously studied by Rioux et al.
[Rioux, J. D., et al. (2000) Am. J. Hum. Genet. 66, 1863–1870]. In their
study, multipoint linkage methods were applied to affected sib-
pairs with inflammatory bowel disease, and significant linkage
evidence points to two susceptibility loci. After we apply our
approach to these data with a global search accounting for both
joint and marginal effects, very interesting results emerge, many
of them intriguing. These results provide compelling support for
the application of our approach to other data wherever applicable.
Results from this project also make it clear that it is important to
reinvestigate available family-based datasets that can be suitably
reanalyzed. Given previously collected data in the literature, our
approach, with its increased efficiency in using available resources,
draws additional crucial information that may lead to novel and
surprising results.
backward haplotype transmission association  genome scan
During the past two decades, a number of novel statisticalmethods have been developed to detect association and
linkage between markers and disease genes. The success, how-
ever, has been largely restricted to simple Mendelian diseases.
For more common and complex human disorders, the progress
from the efforts of searching susceptibility loci using existing
statistical methods has been slow, and the results are often
inconsistent. This result is due in part to the fact that most
current methods make use of marginal information only and fail
to include the useful information of the interaction among the
disease loci. It is thus less likely for these methods to have
adequate power to find the mutated genes. Additionally, at times
a common human disorder may be caused by different sets of
mutated genes in different populations, which adds further
difficulties in identifying the responsible loci. It is no surprise
then that mapping outcomes for complex traits is often unre-
peatable from one study population to another.
To address these difficulties and the pressing need for methods
capable of dealing with large correlated datasets, we have
proposed and developed the backward haplotype transmission
association (BHTA) algorithm (1). The proposed approach
comprises a set of methods that focus on a backward selection
algorithm that deletes unimportant markers one by one until a
subset of (important) markers associated with the disease re-
mains. This algorithm selects a small random subset of the
markers, applies a measure of information on this subset with
respect to the disease, and then reduces the set by the marker
whose deletion contributes the most to increasing the informa-
tion. After successive reductions, the remaining markers are
called ‘‘returned.’’ Those markers that are returned most often
from many random subsets sampled are considered ‘‘important.’’
In this way, both the joint and marginal effects of all markers are
extracted so that the data are analyzed as a whole. As a result,
one can expect the detection of more important genetic loci. We
have applied our approach to a number of simulated datasets,
some of them quite large. Although the results of these simulated
studies were extremely encouraging, we felt it important to test
our approach and to demonstrate its practical values on a real
and large-scale genetic dataset. This report reflects this effort.
The current test data were kindly provided to us by the White-
head Institute for Biomedical Research (Massachusetts Institute
of Technology, Cambridge).
In this report, we present our major findings and illustrate the
application of our methods to a dataset of patients with inflam-
matory bowel disease (IBD) collected in Canada. This dataset of
IBD pedigrees was first studied by Rioux et al. (2), and the
genome-wide search study successfully revealed two susceptibil-
ity loci, 5q31-q33 and 19p13, known today as IBD5 and IBD6.
There have been several other loci with relevance to IBD
etiology identified in the literature since 1996, through various
studies. These loci include IBD1 (16q12), IBD2 (12q13), IBD3
(6p21), IBD4 (14q11), and IBD7 (1p36). For a comprehensive
review of this search history and relevant information about
IBD, see chapter 15 of ref. 3. The wide differences observed
among the results of several genome-wide screens and follow-up
studies since 1996 suggest that the disease might be related to a
number of genes. These genes may have only modest effects on
the susceptibility of IBD and may segregate at different fre-
quencies in the different populations studied. For example, the
study in ref. 2 presented strong evidence supporting the suscep-
tibility of IBD to the loci IBD5 and IBD6 and suggestive
evidence to IBD3, but showed no signs of linkage to the other
previously reported loci such as IBD1, -2, -4, and -7.
As a complex disorder, IBD can be further categorized into
two distinct diseases, Crohn’s disease (CD) and ulcerative colitis
(UC). Whereas the data in ref. 2 included CD, UC, and mixed
families, we received CD data that accounted for roughly 66%
of all data. After we applied our methods to this dataset, we
obtained interesting results, some of them intriguing. For exam-
ple, our selected markers overlapped with all previously reported
IBD loci, except IBD6. Four loci that have shown strong
association with IBD and that have not been reported previously
were also identified.
Materials and Methods
IBD Data. IBD consists principally of UC and CD, two chronic
idiopathic inflammatory diseases of the gastrointestinal tract.
UC and CD are considered together because of their overlap-
ping clinical, epidemiological, and pathogenetic features and
their shared complications and therapies. Cumulative data gar-
nered from epidemiological studies of these IBDs have revealed
that relatives of individuals with either CD or UC are at
increased risk for developing either form of IBD. These obser-
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vations suggest that at least some susceptibility genes will be
shared by UC and CD. For a comprehensive review of IBD and
previous genome-wide screens, see chapter 15 of ref. 3.
Datasets used in this study were retrieved from files (in
LINKAGE format) provided by the Whitehead Institute on a
study investigated in ref. 2. The dataset contains 112 IBD
pedigrees with more than two CD patients (89 with two patients,
20 with three patients, and 3 with four patients), which is 66%
of the original dataset used in ref. 2. Among the patients, only
those with parents on file can be used in the BHTA algorithm;
thus, a total of 235 case–parent trios were finally included.
Although 467 markers were genotyped on the individuals under
study,† 19 of them were monomorphic and 46 had99% missing.
As a result, they were excluded from the screening because they
did not contribute transmission information regarding the trait.
BHTA Screening. The BHTA algorithm is an association-based tool
that evaluates the strength of a subgroup of markers under study.
It deletes unimportant markers that are unassociated with the
trait one by one. The algorithm stops when all remaining markers
show signs of association with the disease and no further
improvements can be achieved by deleting an additional marker.
In this section, to illustrate the main ideas clearly and convinc-
ingly, we will present our main ideas in terms of complete
case–parent trio family data, for which haplotypes are either
known or can be inferred. The implementation of BHTA to IBD
data, dealing with missingness and other practical issues, is given
in the next section.
For simplicity, suppose that k markers are being studied, each
with two alleles only. The idea of marker selection is to pick out
markers that contribute the least information (regarding the
trait) in a dataset, one at a time. The haplotype transmission
disequilibrium (HTD) statistic proposed in ref. 1 as an infor-
mation measure provides a way to achieve this result.
Let SM denote the current set of k markers, SM {M1, M2, . . . ,
Mk}. To evaluate the importance of Mr, 1  r  k, consider SM
r
 SMMr  {M1, M2, . . . , Mˇr,. . . , Mk}, the rth-deleted marker
set. These k  1 markers totally decide H  2k1 possible
haplotypes. Let r  {h1, h2, . . . , hH} be the set of haplotypes
corresponding to SM
r , that is, the haplotypes formed by k  1
markers, with Mr excluded. Given n diseased children in the
dataset, there are 2n parent-to-patient transmission pairs; two
haplotypes are observed for each pair—one transmitted to the
patient and one untransmitted, denoted by ht
(l) and hu
(l), respec-
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where ‘‘#’’ stands for ‘‘count.’’ As the measure of disease
information contained in the k  1 markers of SM











To evaluate the information contributed by Mr, the informa-
tion content of the original SM also needs to be estimated.
Suppose that the two alleles of the rth marker Mr are ar and br.
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u(ar) and ni
u(br)
similarly for non-transmissions of the enlarged parental haplo-
types to the offspring.
It is easy to see that the transmission counts after and before

















As the information remained in the rth-deleted marker set SM
r














From this equation, one finds that the amount of information
lost by deleting marker Mr can be expressed as the difference
between Eqs. 4 and 5, that is,








To track the changes of the HTD score due to the deletion of
the marker Mr, we define a slightly modified statistic, the











which is half of HTDr(k  1) plus an adjusting term
hir narhibrhi whose magnitude is negligible.‡
A positive value of the HTA score indicates that the deleted
marker is less important. Guided by such key properties of HTA
(for more details, see ref. 1), the BHTA algorithm deletes the
least important marker one at a time, where the HTA score is
positive, and at its maximum and continues to the next iteration
until all of the remaining markers present evidence of impor-
tance, that is, HTA scores are negative for all remaining markers.
In practice, the number of markers and their possible inter-
actions included in a large-scale study are often greater than the
number of observations. This moderate size of observations will
cause a serious problem of sparseness in the haplotype data when
dealing with many markers simultaneously. To track the overall
importance of all markers under study without running into the
above issue of dimensionalities and overwhelming computa-
tional complexities, we propose the following two-step marker
selection procedure:
1. Randomly select k (15, for instance) markers of the original
set of K markers. Run BHTA on the selected markers and
record the markers returned.
2. Repeat step 1 B times (B typically  5,000). Markers that are
returned more frequently than others will be selected in the
†According to ref. 2, the data included 377 microsatellite markers that were spaced 12 cM
apart on average, plus additional microsatellite markers genotyped on the IBD5 region.
‡The reason for this adjustment is that the modified score HTAr(k  1) will have an
expectation of zero when no marker is in association with the trait. In fact, the adjusting
termhir narhibrhi carries no information for association and represents a fixed amount
of value loss caused by the deletion of Mr.






resulting set. The criterion used in the present study is based
on the distribution of the returning frequencies of all markers
(see below for details).
For a detailed discussion of this algorithm (such as the choice
of k and B), see ref. 1.
Implementation of BHTA on IBD Data. We applied BHTA two-step
marker selection procedure using the 235 affected children that
determine 4 	 235  940 haplotypes; half of them were
transmitted from parents and the other half untransmitted (for
data preparation, see the next section). Although BHTA was
originally introduced in terms of trio data, its extension to data
with more than one affected child per family is straightforward.
The validity of this extension is mentioned in the footnote on
page 211 of ref. 1. On each set of randomly selected k  15
markers from all markers, we ran BHTA and recorded the
markers returned. Secondly, we repeated this step 100,000 times.
Actually, to minimize the noise due to random imputation (see
the next section for details) for missingness, we used 10 impu-
tations, and the BHTA was run 10,000 times for each. The
combined return frequencies for all markers are plotted in Figs.
3 and 4. The median return is 1,122, which is marked by a
horizontal solid line, whereas the selection threshold (1,325) is
marked by a broken line. As a result, 48 markers (12%) are above
the threshold line. In the same figure, we also included seven
horizontal bars to indicate the seven locations of previously
reported IBD-susceptibility loci IBD1 to -7. All except IBD6 are
included in our final selection of 48 markers.
To determine the selection threshold, we first fitted the
markers’ return frequencies by a simple two-component normal-
mixture model, (1 p) N(1, 1
2)
 pN(2, 2
2), 2 1, whereas
the first component corresponds to the unimportant markers
and the second to the important markers (highly returned).
Although the overall suprema of the likelihood do not provide
sensible estimates, the local maximum does. Therefore, the local
maximum likelihood estimation of the mixture parameter p, with
an estimate of 21.5%, suggests that 81 of the 402 markers belong
to the high mean distribution. The sorted return frequencies of
402 markers in the IBD dataset are plotted in Fig. 1 Upper. The
red line indicates the cumulative distribution function of a single
normal distribution for all markers, and the blue line is the fitted
normal mixture with ˆ1  1,106, ˆ1  94, ˆ2  1,320, ˆ2  213,
and pˆ  0.215 (see density curves in Fig. 1 Lower). To control
the false-positive rate conservatively (holding .01 level, see
vertical broken line in Fig. 1 Lower), we selected the top 48
markers and claimed their importance.
Another method used to separate the important group from the
unimportant group was based on an idea recently developed by
Efron (4). The proposed method suggests the use of an estimated
empirical null distribution to perform the inference when a large
number of tests, say 300 or more, are simultaneously evaluated. The
goal of this application is to divide the data values into two
categories: interesting vs. uninteresting. In place of ‘‘significant’’ vs.
‘‘nonsignificant,’’ Efron (4) used the terms ‘‘interesting’’ vs. ‘‘unin-
teresting’’ in reflecting a difference between a large-scale and a
classical individual testing. In our view, the term ‘‘interesting group’’
corresponds to our term ‘‘important marker group’’ used in this
report. We also felt that the identification of important markers (or
interesting markers) at this stage was more of a screening operation,
which intended to reduce the marker size to a much smaller order
so that further efforts and investigations can be properly directed.
We now apply Efron’s method (and similar notations) to our
data-return frequencies.
Let z be the return frequency of a marker under evaluation, the
distribution density function of z, f(z), is a mixture of two distribu-
tions, f0(z) (the unimportant group) and f1(z) (the important
group), i.e., it takes the form f(z)  p0f0(z) 
 p1f1(z), where p0 and
p1 are prior probabilities of the important and unimportant groups.
Fig. 1. Normal vs. normal mixture.
Fig. 2. Histogram of return frequencies with fitted f(z) and local false
discovery rate fdr(z). (Upper) The distribution of return frequencies f(z) was
estimated by fitting a natural spline to the histogram counts based on 40 equal
intervals. (Lower) The horizontal broken line indicates the 0.1 fdr threshold for
important marker group, which leads to a return frequency threshold of 1,330
(the vertical dotted line). A total of 47 markers that had return frequencies
higher than this threshold were selected for the important group.
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As suggested in ref. 4, (i) f(z) was estimated by the natural spline
(df 13) fitted to the histogram counts based on 40 equal intervals
(as shown in Fig. 2 Upper); (ii) f0(z) was estimated by N(0, 	0
2),
where 0  1,090 and 	0  82 were the center and the half-width
of the central peak of f(z), respectively; (iii) the local false discovery
rate fdr(z) was calculated as fdr f0(z)f(z) (see Fig. 2 Lower); and
(iv) the same selection criterion used in ref. 4, fdr 0.1, was applied
to these return frequencies, which yielded a threshold of 1,330,
leading to a final selection of top 47 markers. The final result
differed only by one marker from the first method we used. For
details on the justification and implementation of this method, see
ref. 4.
Data Preparation for BHTA. Before the BHTA screening algorithm
can be implemented on this dataset, several data manipulation
steps are required: (i) imputation of missing genotypes, (ii)
inference of haplotypes given multilocus unphased genotypes,
and (iii) dichotomization of microsatellite markers.
To reduce random noises resulted from imputations and other
data manipulation, we ran independent BHTA screenings on 10
independently prepared datasets (imputation, inference, and
dichotomization). The major findings in this report were based
on aggregated results from these 10 independent trials. The
aggregation of independent trails reduced noise caused by
random imputation and thus honestly reflected the strength of
the individual markers’ real signal of importance.
Imputation for missing parental genotypes. Genetic data from a
large-scale genome scan inevitably contain a substantial number
of missing values due to genotyping errors or unavailable par-
ents. For haplotype-based methods such as BHTA, one must
obtain genotype information on all markers for any individual
under study. It is essential to circumvent the issue of missing by
proper imputation. For current IBD data,20% of the genotype
data were missing for any individual under study whereas the
mean amounts were as high as 47%. However, one can infer the
missing genotypes using the observed genotypes of other family
members (affected or unaffected), perfectly (7% of the time) or
probabilistically (93% of the time).
We started with the imputation on missing parental genotypes
for two reasons: (i) there were slightly fewer missing values in the
children’s genotypes and (ii) unaffected child(ren) in the data
provided information for the imputation of parental missing
genotypes, even though they were not used in the screening. The
imputation was carried out by using posterior probabilities of
possible full genotypes given observed parental and children’s
genetic information, marker-by-marker.§ Given a pair of parents
§Certainly, considering the observed genotype on markers nearby will provide more
information for the imputation. However, given the disease status of the children, the
association among markers has been contaminated by their possible association with the
disease trait.
Fig. 3. BHTA return frequencies: chromosomes (Chr) 1–9 aggregated return frequencies from BHTA screens are plotted vs. marker locations on the genome.
Only markers included in the screening are shown. The median return (1,122) is marked by a horizontal solid line, whereas the selection threshold (1,325) is
marked by a broken line. A total of 48 markers with return frequencies above the threshold are selected and labeled with their names for reference (except for
the IBD5 region). Discussion on the selection threshold is presented in Implementation of BHTA on IBD Data. Seven horizontal bars indicate the previously
reported IBD-susceptibility loci, IBD1–IBD7. All except IBD6 are included in the selection.






of the affected children under study, with missing genotypes at




m) to be a possible full




m denote the unordered
genotypes for the father and mother, respectively. The likelihood
of gi being the true genotypes is then
P full parental genotypes gi
observed parental and child(ren)’s genotypes)
 P(observed child(ren)’s genotypes  full parental genotypes gi

 P (full genotypes gi  observed parental genotypes). [8]
After having evaluated all possible gi’s, we drew one gi according
to the posterior probabilities to finish the imputation. To avoid
possible bias, all probability calculations were done under the
assumption of no association to the disease trait.
With a complete parental genotype, the imputation of missing
genotype for the affected children became trivial and was carried
out during the inference of multiloci haplotype phases (see
below).
Inference on haplotype phases from multilocus unordered genotypes.
After the previous imputation step, parental data were free of
missing values. The inference of gametic haplotypes given mul-
tilocus unphased genotypes was then carried out by determining
the transmitted and untransmitted alleles for each parent-child
pair at each marker locus. The inference was implemented under
five different scenarios (see Supporting Text, which is published
as supporting information on the PNAS web site).
Dichotomization for microsatellite markers. Because the BHTA algo-
rithm primarily works with diallelic markers, we dichotomized
the microsatellite markers according to their numbers of repeats
(0 if lower than a prespecified value, 1 otherwise), with proba-
bility of ‘‘allele 0’’ as close to 0.5 as possible.
Results
Our global search, accounting for both joint and marginal
effects, has resulted in a selection of 48 (of a total of 402)
important markers that are potentially related to the disease
susceptibility (a complete list of these 48 markers is given in
Table 3, which is published as supporting information on the
PNAS web site). These 48 markers are spread across many of the
23 chromosomes (see Figs. 3 and 4).
Table 1. Selected important markers on IBD loci
IBD locus Selected marker
IBD 1 (16q12) D16S769
IBD 2 (12q13) D12S1052
IBD 3 (6p21) DRB1
IBD 4 (14q11) D14S297
IBD 5 (5q31) CAh816*
IBD 6 (19p13)
IBD 7 (1p36) D1S1612
*Twenty-one of 74 markers around the IBD5 locus are selected.
Fig. 4. BHTA return frequencies: chromosomes (Chr) 10–23 aggregated return frequencies from BHTA screens are plotted vs. marker locations on the genome.
See legend of Fig. 3.
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Confirmation of Previously Identified IBD Loci. Despite the fact that
no linkage evidence was found on other IBD loci (loci 1, 2, 4, and
7) in ref. 2, our selected markers overlap with all previously
reported IBD loci, except IBD6 (see Table 1), suggesting that
these data contain considerable information that may have not
been used in the earlier analysis. The discrepancy of the findings
between these two studies provides evidence supporting the use
of methods that take into account interactions and extract more
of the information available in the data. With conventional
approaches, much of the information would not be captured, and
many responsible regions are likely to be missed. In addition, our
findings independently confirm the evidence of susceptibility in
the regions of IBD1 to -4 and -7, which have been reported in
other studies based on different datasets.
Loci Demonstrating Important Association to IBD. In our approach,
the importance of each marker under study is evaluated by its
returned frequencies; this number provides a natural way to rank
the importance of markers. Treating the distribution of returned
frequencies as a mixture of two distributions, one representing
the important markers and the other for unimportant markers,
we may estimate the parameters of this mixture model and
separate out the important markers accordingly. The selection of
important markers was achieved through two statistical methods
dissecting such a mixture, which returned almost identical re-
sults: we selected the top 48 markers (with high return frequen-
cies) and claimed their importance. Furthermore, among the 48
selected markers, the four markers returned most frequently
(besides some IBD5 markers) are D1S549 (1q), D5S1470 (5p),
D8S592 (8q), and D21S1446 (21q), pointing to four previously
uncharacterized loci, none of which have been reported in the
present literature. Given that these signals are very strong,
further research on these regions could be very fruitful. We
identified¶ several genes on these loci that may be of interest to
researchers (listed in Table 2). We also believe that medical
researchers with expertise in IBD may provide further important
insights into these loci.
In view of the above findings, it seems important to reinvestigate
available family-based datasets that can be suitably reanalyzed by
our methods. Because these samples have been collected already,
our approach could increase the efficiency of using available
resources and obtain additional crucial information.
Discussion
The application of our methods on the IBD data provided
significant additional findings that seem above and beyond
previously expected and researched results. The major weakness
of conventional approaches is that the mapping outcomes are
usually unrepeatable from one study to another. This outcome
is due in part to the fact that most methods use fractional
information from the data. Consequently, the power of detecting
those responsible genes with modest effects is seriously reduced.
Our approach intends to draw substantially more information
from data and subsequently rank all markers according to their
overall contributions (reflected by their importance) toward
disease. The overall contribution of each marker is measured by
its returned frequency (described above) that honestly reflects
both the joint (interactive) and marginal effects in the disease
etiology. We believe that the proposed approach will also be
useful in the future when the information of a large number of
dense markers (single nucleotide polymorphisms, for example)
becomes available. In the meantime, we strongly recommend
that the data already collected be suitably reanalyzed by this
approach. We believe that outcomes of these reexaminations
could lead to very fruitful and interesting results. The joint
returning patterns of subsets of markers carry valuable infor-
mation about disease clusters, networks, and pathways. This
direction deserves further investigation.
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Table 2. Candidate genes at four loci
Marker Locus Gene Notes
D1S549 1q32.1 MDM4 Plays a role in apoptosis*; shows significant structural similarity to p53-binding protein MDM2.
IL24 Encodes a member of the IL10† family of cytokines; protein encoded is found to induce apoptosis.
IL20 The protein encoded by this gene is a cytokine structurally related to IL-10.
CD55 Or DAF‡, decay accelerating factor for complement (Cromer blood group system).
D5S1470 5p15.2 DAP Acts as a positive mediator of programmed cell death (apoptosis).
D8S592 8q24.12 MTBP Codes MDM2, transformed 3T3 cell double minute 2, p53 binding protein.
D21S1446 21q22 DSCR1 Down syndrome critical region 1.
*IBD have been previously found to evoke the activation of apoptotic genes.
†It has been previously found that lack of IL-10 may lead to intestinal inflammation (5).
‡DAF, or CD55, has been found to have an important role in regulating gut homeostasis and may participate in protecting against IBD (6).
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